MeSH D003428 - cross infection
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D007049:Iatrogenic disease
0 Companies
0 Drugs
Success rate
D003428:
Cross infection
D000077299:Healthcare-associated pneumonia
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Johnson & Johnson | Doripenem | Doribax | 2008-07-25 |
Clinical Trials
Historical Success Rate
Phase 1
100%3/3
Phase 2
36%5/14
Phase 3
58%11/19
Approved: 2Overall Success rate: 21%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use